Post-trial obligations and participant enrollment in brain pioneering research
Should we expand inclusion criteria?
Bibliographic Data
| ID | 22422659 |
|---|---|
| Authors | Chris Bobier (0000-0003-4194-4721, Central Michigan University, corresponding author), Christopher Bobier, Daniel J Hurst (0000-0003-0592-2592, Rowan University) |
| Year | 2026 |
| Publication date | 2026-07-11 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Medicine Health Care and Philosophy (JOURNAL) |
| Journal identifiers | ISSN: 1386-7423 • E-ISSN: 1572-8633 |
| Publisher | Springer Science and Business Media LLC (PUBLISHER) |
| DOI | 10.1007/s11019-026-10380-0 |
| PMID | 42435253 |
| OpenAlex | W7168028473 |
| Language | EN |
| References cited | 50 |
Medical law · Neuroethics · Philosophy of biology · Philosophy of medicine · Biomedical Ethics and Regulation · Ethics in Clinical Research · Neuroethics, Human Enhancement, Biomedical Innovations
Need for greater post-trial support for clinical trial participants assessing high-risk, irreversible treatments
Non-voluntary BCI explantation
Selecting participants fairly for controlled human infection studies
Engineering the Brain
Brain Pioneers and Moral Entanglement
Identity Theft, Deep Brain Stimulation, and the Primacy of Post‐trial Obligations
Monitoring and Manipulating Brain Function
| Citation velocity | historical |
|---|---|
| Highly cited | No |